9th Dec 2016 08:19
LONDON (Alliance News) - Shares in medical devices firm Creo Medical Group PLC surged as the company made its debut on London's AIM market on Friday.
Creo raised GBP20.0 million via a placing at 76.00 pence per share. Its market capitalisation upon admission on Friday will be around GBP61.3 million.
Early on Friday, its shares were trading at 85.00 pence, up 12% from the float price.
Creo is a Chepstow, South Wales-based surgical endoscopy specialist. It has developed an electrosurgical platform able to deliver microwave and bipolar radiofrequency through a single accessory port.
This makes it possible to carry out endoscopic surgery, a recent development in the field of minimally invasive surgery, by allowing miniature devices to cut, coagulate and ablate with precision, Creo said.
By Sam Unsted; [email protected]; @SamUAtAlliance
Copyright 2016 Alliance News Limited. All Rights Reserved.
Related Shares:
Creo Medical